Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up

Ad

KITTEE (KTE) TRC20 Token

ANIK News and Press Anika Therapeutics Inc.


home / stock / anik / anik news

RSS
ANIK ANIK Quote ANIK Short ANIK News ANIK Articles ANIK Message Board
  • Anika Therapeutics, Inc. (ANIK) Q3 2022 Earnings Call Transcript

    Anika Therapeutics, Inc. (ANIK) Q3 2022 Results Conference Call November 08, 2022 05:00 PM ET Company Participants Mark Namaroff - Vice President, Investor Relations, ESG and Corporate Communications Dr. Cheryl Blanchard - President and Chief Executive Officer Mi...

    • November 08, 2022 08:31:04 pm
    • |
    • SeekingAlpha
    • |
      • ANIK Stock
      • ANIK Quote
      • ANIK Short
      • ANIK News
      • ANIK Articles
      • ANIK Message Board
  • Anika Therapeutics Non-GAAP EPS of -$0.05 beats by $0.18, revenue of $40.3M beats by $2.71M

    Anika Therapeutics press release ( NASDAQ: ANIK ): Q3 Non-GAAP EPS of -$0.05 beats by $0.18 . Revenue of $40.3M (+1.9% Y/Y) beats by $2.71M . For further details see: Anika Therapeutics Non-GAAP EPS of -$0.05 beats by $0.18, revenue of $40.3M beats by $2....

    • November 08, 2022 04:40:34 pm
    • |
    • SeekingAlpha
    • |
      • ANIK Stock
      • ANIK Quote
      • ANIK Short
      • ANIK News
      • ANIK Articles
      • ANIK Message Board
  • Anika Reports Third Quarter Fiscal 2022 Financial Results

    Third Quarter Revenue Growth of 2% Third Phase III Clinical Trial for Cingal®, Next Generation Osteoarthritis Pain Product, Achieved Primary Endpoint Demonstrating Superiority Over Steroid Alone Pivotal Phase III Clinical Trial for Hyalofast®, HA-Based, Single-...

    • November 08, 2022 04:05:00 pm
    • |
    • GlobeNewswire
    • |
      • ANIK Stock
      • ANIK Quote
      • ANIK Short
      • ANIK News
      • ANIK Articles
      • ANIK Message Board
  • Anika's Cingal® Successfully Achieves Primary Endpoint in Third Phase III Study

    Study Demonstrated Superiority of Cingal, a Single-Injection Hyaluronic Acid-Based Viscosupplement Combined with Fast-Acting Steroid, Over Steroid Alone, for Osteoarthritis Pain Relief at 26 Weeks Study Builds on Prior Phase III Study Data that Demonstrated Superiority over Plac...

    • November 01, 2022 08:00:32 am
    • |
    • GlobeNewswire
    • |
      • ANIK Stock
      • ANIK Quote
      • ANIK Short
      • ANIK News
      • ANIK Articles
      • ANIK Message Board
  • Anika to Issue Third Quarter 2022 Financial Results on Tuesday, November 8, 2022

    BEDFORD, Mass., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue its third quarter 2022 financial results after the close of the market on Tue...

    • October 25, 2022 09:25:20 am
    • |
    • GlobeNewswire
    • |
      • ANIK Stock
      • ANIK Quote
      • ANIK Short
      • ANIK News
      • ANIK Articles
      • ANIK Message Board
  • Anika Announces First Surgeries Performed Using the X-Twist(TM) Fixation System and Commences Limited Market Release

    BEDFORD, Mass., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced the limited market release and the first surgeries performed using the X-Twist Fixation System. Chr...

    • September 12, 2022 04:01:49 pm
    • |
    • GlobeNewswire
    • |
      • ANIK Stock
      • ANIK Quote
      • ANIK Short
      • ANIK News
      • ANIK Articles
      • ANIK Message Board
  • Anika Therapeutics Inc. (ANIK) CEO Cheryl Blanchard on Q2 2022 Results - Earnings Call Transcript

    Anika Therapeutics, Inc. (ANIK) Q2 2022 Earnings Conference Call August 03, 2022, 05:00 PM ET Company Participants Mark Namaroff - Vice President, Investor Relations, ESG and Corporate Communications Cheryl Blanchard - President and Chief Executive Officer Michae...

    • August 06, 2022 04:40:04 am
    • |
    • SeekingAlpha
    • |
      • ANIK Stock
      • ANIK Quote
      • ANIK Short
      • ANIK News
      • ANIK Articles
      • ANIK Message Board
  • Anika Therapeutics, Inc. 2022 Q2 - Results - Earnings Call Presentation

    The following slide deck was published by Anika Therapeutics, Inc. in conjunction with their 2022 Q2 earnings call. For further details see: Anika Therapeutics, Inc. 2022 Q2 - Results - Earnings Call Presentation

    • August 06, 2022 03:09:42 am
    • |
    • SeekingAlpha
    • |
      • ANIK Stock
      • ANIK Quote
      • ANIK Short
      • ANIK News
      • ANIK Articles
      • ANIK Message Board
  • Anika Therapeutics Non-GAAP EPS of -$0.12 beats by $0.09, revenue of $39.7M beats by $1.85M

    Anika Therapeutics press release ( NASDAQ: ANIK ): Q2 Non-GAAP EPS of -$0.12 beats by $0.09 . Revenue of $39.7M (+4.2% Y/Y) beats by $1.85M . The Company continues to expect its overall revenue for fiscal year 2022 to be toward the upper end of its guidance ran...

    • August 03, 2022 04:35:39 pm
    • |
    • SeekingAlpha
    • |
      • ANIK Stock
      • ANIK Quote
      • ANIK Short
      • ANIK News
      • ANIK Articles
      • ANIK Message Board
  • Anika Reports Second Quarter Fiscal 2022 Financial Results

    Second quarter revenue growth up 4% X-Twist ™ 510(k) clearance received; Limited market release on schedule for 2H 2022 BEDFORD, Mass., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in earl...

    • August 03, 2022 04:05:21 pm
    • |
    • GlobeNewswire
    • |
      • ANIK Stock
      • ANIK Quote
      • ANIK Short
      • ANIK News
      • ANIK Articles
      • ANIK Message Board
Next 10
Stock Information

Anika Therapeutics Inc. Company Name:

ANIK Stock Symbol:

NASDAQ Market:

Anika Therapeutics Inc. Website:

Anika Therapeutics Inc. Logo

Get ANIK Alerts

News, Short Squeeze, Breakout and More Instantly...

Ad

KITTEE (KTE) TRC20 Token
RECENT ANIK NEWS
  • Research
  • Stock Search
  • News Releases
  • Articles
  • Message Boards
  • Trending Stocks
  • Short Information
  • Stock Wall
  • Coins
  • Link Twitter
  • Sign Up
  • Login
  • Contact

Article Banner Advertisement Program

Boost your Articles

The Banner Advertisement Program is designed to Boost your article through a targeted audience.

p>

Pricing and information can be found here.Coins

Each coin will allow 12 hours of Banner advertisement placement everywhere on the Market Wire News platform, included in all emails and other various CWN Media platformsIt also inclused pop up to any new visitor to the site..

Once you receive the coins you can start the advertisement by clicking the button located next to your article in your list of article in your list of articles.

Every twelve hours the ads will automatically stop. You may continue the advertisement for another twelve hours at any time by pressing the button located next to your article in your list of articles. Each time you continue a coin will be withdrawn from your account.

Sign up or login to continue

Sign up or login to continue.


Forgot password?




Mobile Number Subscribers

Market Wire News provides notifications to customers about updates, service, reminders, or products. Current and new customers of Market Wire News will enter their mobile numbers on a web opt-in form https://marketwirenews.com. Supported Carriers are as follows Alltel, AT&T, Cincinnati Bell, Dobson Cellular Systems, Inter Op, MetroPCS®, Nextel Communications, Sprint PCS, T-Mobile®, U.S. Cellular®, Verizon Wireless, and Virgin Mobile U.S. T-Mobile® is not liable for delayed or undelivered messages. There are no premium charges for joining Market Wire News service. Message and data rates may apply. Subscribers to Market Wire News service may receive up to 500 per month.

How to Opt Out

To opt-out of the Market Wire News program, send or text STOP, END, QUIT, CANCEL or UNSUBSCRIBE to (844) 931-3999. An unsubscribe message will be sent to your number confirming the cancellation, but no more messages will be sent after that one.

Mobile Support

For support or information about a Market Wire News, send or text HELP to (844) 931-3999. Optionally, you may email support@marketwirenews.com.

WATCH LIVE TRENDING STOCKS

Advertise

Brand your company, advertise your products or services with our ad programs.

Advertise

Research

Stock Search

News Releases

Articles

Message Boards

Trending Stocks

Short Information

Stock Wall

Members

Log In

Sign Up

Stay Connected

Follow @marketwirenews

| Facebook

| Telegram

| LinkedIn

| Reddit

| Discord


Contact

Privacy

Terms of Service

Disclaimer

© 2023 Market Wire News